2006
DOI: 10.1016/j.bbrc.2006.06.195
|View full text |Cite
|
Sign up to set email alerts
|

Müllerian inhibiting substance as a novel biomarker of cisplatin-induced ovarian damage

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
38
0

Year Published

2011
2011
2023
2023

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 45 publications
(39 citation statements)
references
References 35 publications
1
38
0
Order By: Relevance
“…This protocol has been used previously by our laboratory and has been demonstrated to adversely affect the ovarian function of female rats. 6,22 The animals were given one IP injection of saline or cisplatin (4.5 mg/kg) once a week for two weeks. Ten milliliters (mls) of sterile 0.9% NaCl was administered subcutaneous (SQ) once a week over multiple injection sites and additionally as needed to prevent dehydration.…”
Section: Experiments 1: Cisplatin Reproductive Toxicitymentioning
confidence: 99%
See 1 more Smart Citation
“…This protocol has been used previously by our laboratory and has been demonstrated to adversely affect the ovarian function of female rats. 6,22 The animals were given one IP injection of saline or cisplatin (4.5 mg/kg) once a week for two weeks. Ten milliliters (mls) of sterile 0.9% NaCl was administered subcutaneous (SQ) once a week over multiple injection sites and additionally as needed to prevent dehydration.…”
Section: Experiments 1: Cisplatin Reproductive Toxicitymentioning
confidence: 99%
“…In rats, cisplatin has previously been shown to cause damage to the ovaries by increasing the percentage of follicular apoptosis and follicular cyst formation in rats. 6,7 In animal models, several studies have been performed on the effects of cisplatin administration during pregnancy. Administration of cisplatin during pregnancy in mice and rats resulted in fetal mitochondrial toxicity, DNA adduct formation, and increased incidence of tumors of kidney, skin, lung and other organs.…”
Section: Introductionmentioning
confidence: 99%
“…It was reported that chemotherapeutic medicines leading to either temporary or permanent infertility severely affected the ovaries and hormonal balance (DeVita et al 2005). In rats, CDDP has been shown to cause ovarian damage, at varying degrees ranging from minimal effects to ovarian failure, increased follicular apoptosis, decreased expression anti-Müllerian hormone (AMH), alterations in the estrous cycle, and a decrease in the number of AMH-producing follicles (Borovskaya et al 2004;Yucebilgin et al 2004;Yeh et al 2006Yeh et al , 2008. Our study has demonstrated that CDDP caused significant toxicity in the ovarian tissues of rats.…”
Section: Discussionmentioning
confidence: 69%
“…They claimed that addition of Leuprorelin acetate protected primordial follicles from harmful effect of CDDP. Yeh et al (2006) utilized the antioxidant sodium-2-mercaptoethanesulfonate (mesna) to preserve ovaries from CDDP induced toxic effect in rat model. It was found that the administration of mesna during low-dose CDDP treatment protected the ovaries by decreasing the loss of growing follicles in the ovaries (Yeh et al 2008).…”
Section: Discussionmentioning
confidence: 99%
“…Our results were also in line with these findings as revealed by the impaired integrity of the surrounding granulosa layer in most of the follicles examined and significantly reduced number of primordial cells in cisplatin alone treated rats. Of course the damaging effects of cisplatin on ovarian follicles have been previously reported [49,50]. Yucebilgin et al [1] reported a significantly damage primordial follicles in rats after a single dose of cisplatin (5 mg/kg) and paclitaxel (7.5 mg/kg) [1].…”
Section: The Morphological Effectsmentioning
confidence: 99%